Evaluation of Refractive Errors and Ocular Biometric Outcomes after Intravitreal Bevacizumab for Retinopathy of Prematurity

Gunay M., ŞEKEROĞLU M. A., Bardak H., ÇELİK G., ESENÜLKÜ C. M., HEKİMOĞLU E., ...More

STRABISMUS, vol.24, no.2, pp.84-88, 2016 (ESCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 24 Issue: 2
  • Publication Date: 2016
  • Doi Number: 10.3109/09273972.2016.1159232
  • Journal Name: STRABISMUS
  • Journal Indexes: Emerging Sources Citation Index (ESCI), Scopus
  • Page Numbers: pp.84-88
  • Keywords: Biometry, intravitreal injection, refraction, retinopathy of prematurity, THRESHOLD RETINOPATHY, PRETHRESHOLD RETINOPATHY, LASER PHOTOCOAGULATION, DIODE-LASER, VISUAL FUNCTION, CRYOTHERAPY, INFANTS, CHILDREN, EYES, THERAPY
  • Karadeniz Technical University Affiliated: No

Abstract

Purpose: To assess ocular biometric outcomes following intravitreal bevacizumab (IVB) monotherapy for retinopathy of prematurity (ROP) and compare these results with those of laser photocoagulated infants and with the ones with spontaneously regressed ROP.